Allogeneic hematopoietic SCT (HCT) offers potentially curative therapy for patients with hematologic malignancies, but also carries significant risks. Assessing potential risk versus benefit is a ...
CHARLOTTESVILLE, Va., Dec. 16, 2021 (GLOBE NEWSWIRE) -- Diffusion Pharmaceuticals Inc. (NASDAQ: DFFN) (“Diffusion” or the “Company”), a biopharmaceutical company developing novel therapies that ...
Effect of branched-chain amino acid metabolic interactions between HIBADH+ tumor cells and BCAT1+ macrophages on immunotherapy response in advanced NSCLC. Baseline DLCO 1.04 (0.99-1.1);p=0.1 1.04 ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results